Lazard Asset Management
ARIA

Lazard Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Lazard Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,000
Closed -$17K – 1181
2015
Q3 		$17K Buy
+3,000
New +$23.1K ﹤0.01% 980
2014
Q3 		– Sell
-225,800
Closed -$1.44M – 1122
2014
Q2 		$1.44M Buy
+225,800
New +$1.55M ﹤0.01% 684
2013
Q4 		– Sell
-749,243
Closed -$13.8M – 1075
2013
Q3 		$13.8M Sell
749,243
-38,830
-5% -$754K 0.03% 293
2013
Q2 		$13.8M Buy
+788,073
New +$14M 0.03% 295

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Lazard Asset Management's ARIA Position: Q4 2015 in Review

Lazard Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2015, closing a stake of 3,000 shares — an estimated $17K sold.

Lazard Asset Management first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $13.8M in Q3 2013. 172 funds tracked by Wall St. Rank hold ARIA as of Q4 2015.

  • Lazard Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Lazard Asset Management sold 3,000 Ariad Pharmaceuticals Inc shares in Q4 2015, an estimated $17K.
  • Lazard Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Lazard Asset Management's Ariad Pharmaceuticals Inc position peaked at $13.8M in Q3 2013.
  • 172 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2015.

Based on Lazard Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.